Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin in advanced breast cancer
NCT00050427Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2002
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 2 trial of trabectedin in breast cancer, sponsored by Johnson & Johnson. Started Dec 2002; status: completed.
02
Drugs
trabectedin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00050427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00050427.